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CRISPR methods for product discovery and fungal cell factory construction 
 
The rapidly increasing number of fully sequenced fungal genomes constitutes a goldmine of new 
research possibilities. However, for most newly sequenced species, exploitation of this potential is 
hampered by low gene targeting frequencies. We have therefore developed a flexible CRISPR/Cas9 
toolbox adapted for filamentous fungi to facilitate genome editing. Our toolbox currently contains a set 
of four AMA1 based vectors with different selections markers, which all contain a cas9 gene codon 
optimized for Aspergillus niger and a USER cloning cassette for simple insertion of the sequences 
encoding sgRNA. Moreover, we have also developed an sgRNA design software that facilitates 
identification of sgRNA sequences that can target a desired gene in several different species, hence, 
reducing the plasmid construction workload. To investigate the versatility of our system we have 
embarked on a project aiming at testing tool parts in the black Aspergillus species where several 
species have not previously been genetically engineered. To address the efficiency of the system and 
to facilitate future work, we initially introduce mutations in homologs of the pigment gene albA and in 
the marker gene pyrG. In species where CRISPR-Cas9 works efficiently, we envision that it will now 
be possible to rapidly address specific scientific questions by changing or eliminating specific gene 
functions using our system directly; or by using it to eliminate the NHEJ pathway setting the stage for 
conventional gene targeting. We will provide examples of this strategy. CRISPR-Cas9 may also be 
advantageously used for cell factory construction as our versatile system allows genes to inserted 
and tested for activity in several different species using the same building blocks. In this way the 
repertoire of strains for production of a given product can be quickly tested and the best host chosen 
at an early point. For examining pathways in more detail or for metabolic engineering purposes, we 
are investigating the possibility of editing genes by RNA guided Cas9 activity using oligo-nucleotides 
as repair template for the repair of the resulting DNA DSBs. We have shown that it is possible to 
introduce defined point mutations in specific genes using this strategy in a number of genes. 
Efficiencies and possibilities will be discussed.  
 
 
  
